Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management

J Kabeerdoss, RK Pilania, R Karkhele… - Rheumatology …, 2021 - Springer
Multisystem inflammatory syndrome (MIS-C) is a pediatric hyperinflammation disorder
caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It has now been …

Cutaneous findings following COVID‐19 vaccination: review of world literature and own experience

T Gambichler, S Boms, L Susok… - Journal of the …, 2022 - Wiley Online Library
There is growing evidence that not only the novel coronavirus disease (COVID‐19) but also
the COVID‐19 vaccines can cause a variety of skin reactions. In this review article, we …

Skin manifestations associated with COVID-19: current knowledge and future perspectives

G Genovese, C Moltrasio, E Berti, AV Marzano - Dermatology, 2021 - karger.com
Abstract Background: Coronavirus disease-19 (COVID-19) is an ongoing global pandemic
caused by the “severe acute respiratory syndrome coronavirus 2”(SARS-CoV-2), which was …

Systemic and organ-specific immune-related manifestations of COVID-19

M Ramos-Casals, P Brito-Zerón… - Nature Reviews …, 2021 - nature.com
Immune-related manifestations are increasingly recognized conditions in patients with
COVID-19, with around 3,000 cases reported worldwide comprising more than 70 different …

Post COVID-19 condition in children and adolescents: an emerging problem

J Izquierdo-Pujol, S Moron-Lopez, J Dalmau… - Frontiers in …, 2022 - frontiersin.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection became a
pandemic in 2020 and by March 2022 had caused more than 479 million infections and 6 …

Autoimmune and rheumatic manifestations associated with COVID-19 in adults: an updated systematic review

KT Tang, BC Hsu, DY Chen - Frontiers in immunology, 2021 - frontiersin.org
Background: Numerous cases of the coronavirus disease 2019 (COVID-19) with
autoimmune and rheumatic manifestations have been reported. Despite the available …

Skin manifestations of COVID‐19 in children: part 1

D Andina, A Belloni‐Fortina, C Bodemer… - Clinical and …, 2021 - academic.oup.com
The current COVID‐19 pandemic is caused by the SARS‐CoV‐2 coronavirus. The initial
recognized symptoms were respiratory, sometimes culminating in severe respiratory distress …

SARS‐CoV‐2, COVID‐19, skin and immunology–What do we know so far?

N Novak, W Peng, MC Naegeli, C Galvan… - Allergy, 2021 - Wiley Online Library
The pandemic condition coronavirus disease (COVID‐19), caused by the novel severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), can take asymptomatic, mild …

Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblain-like lesions during the COVID-19 pandemic

T Hubiche, N Cardot-Leccia, F Le Duff… - JAMA …, 2021 - jamanetwork.com
Importance Chilblain-like lesions have been reported during the coronavirus 2019 (COVID-
19) pandemic. The pathophysiology of such manifestations remains largely unknown …

Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies

MT Patrick, H Zhang, R Wasikowski, EP Prens… - Journal of Allergy and …, 2021 - Elsevier
Background Coronavirus disease 2019 (COVID-19) is commonly associated with skin
manifestations, and may also exacerbate existing skin diseases, yet the relationship …